Andrew Tsai

Andrew Tsai is a Senior Vice President at Jefferies, where they lead coverage in various biotech stocks, including MRNS, SAGE, and ITCI. With over seven years of independent investing experience as a Retail Stock Investor from 2006 to 2013, Andrew achieved a return of over 300%. They have also served as an Equity Research Associate at Wedbush Securities and a Senior Equity Research Associate at RBC Capital Markets. Andrew holds a Bachelor of Science degree in Environmental/Environmental Health Engineering from the University of California, Irvine, and a Master of Science from Stanford University.